These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8974495)

  • 21. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
    Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
    Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
    Le Dévéhat C; Khodabandehlou T; Mosnier M
    Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipid peroxidation and protein glycosylation in the aorta of rabbits with alloxan diabetes during insulin correction].
    Khegaĭ MD; Zaĭchik SE
    Patol Fiziol Eksp Ter; 1995; (4):6-7. PubMed ID: 8700599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in erythrocyte aggregability in diabetics: the influence of plasmatic fibrinogen and phospholipids of the red blood cell membrane.
    Martínez M; Vayá A; Server R; Gilsanz A; Aznar J
    Clin Hemorheol Microcirc; 1998 Jul; 18(4):253-8. PubMed ID: 9741665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of naftidrofuryl on the contraction and proliferation of cultured myocytes evoked by serotonin.
    Bodin P; Travo P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S25-8. PubMed ID: 1369713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress status in patients with diabetes mellitus: relationship to diet.
    Dierckx N; Horvath G; van Gils C; Vertommen J; van de Vliet J; De Leeuw I; Manuel-y-Keenoy B
    Eur J Clin Nutr; 2003 Aug; 57(8):999-1008. PubMed ID: 12879095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serotonin antagonism and uterine activity].
    Lechner W; Sölder E; Kölle D
    Z Geburtshilfe Perinatol; 1991; 195(6):260-1. PubMed ID: 1776315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.
    Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Levels of beta-thromboglobulin in type I diabetes mellitus. Effect of dipyridamole].
    Amado JA; Suárez M; Vadillo V; Vidal JI; Mazo E
    Rev Clin Esp; 1983 Sep; 170(6):283-5. PubMed ID: 6197727
    [No Abstract]   [Full Text] [Related]  

  • 31. [Inhibition of the spasmogenic effect of exogenous and endogenous serotonin on isolated blood vessels by naftidrofuryl].
    Verheggen R; Schrör K
    Vasa Suppl; 1988; 24():5-10. PubMed ID: 3212604
    [No Abstract]   [Full Text] [Related]  

  • 32. Evolution of serum alpha-tocopherol in the postprandial and postabsorptive phases in type 1 diabetes mellitus.
    Manuel-y-Keenoy B; Van Campenhout A; Vertommen J; Van Gaal L; De Leeuw I
    Ann N Y Acad Sci; 2004 Dec; 1031():439-42. PubMed ID: 15753191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Factors influencing the structural-functional properties of erythrocyte membranes in pregnant women].
    Mikaelian NP; Maksina AG; Kniazev IuA; Mikaelian AV
    Biull Eksp Biol Med; 1997 Jan; 123(1):26-8. PubMed ID: 9213450
    [No Abstract]   [Full Text] [Related]  

  • 34. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
    Androne L; Gavan NA; Veresiu IA; Orasan R
    In Vivo; 2000; 14(2):327-30. PubMed ID: 10836205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocyte membrane cholesterol content in juvenile diabetes. Preliminary communication.
    Sarnecka-Keller M; Kordowiak A; Ciba T
    Acta Med Pol; 1980; 21(3):253-6. PubMed ID: 7246218
    [No Abstract]   [Full Text] [Related]  

  • 36. [Changes in erythrocyte membrane resistance during the development of endotoxin shock].
    Nefedova TV; Kubatiev AA
    Patol Fiziol Eksp Ter; 1991; (4):20-2. PubMed ID: 1798643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Erythrocyte membrane sodium transport in patients with type I diabetes mellitus (insulin-dependent diabetes mellitus)].
    Pelikánová T; Krízová J; Smrková I; Pinsker P
    Cas Lek Cesk; 1998 Jul; 137(14):434-7. PubMed ID: 9748739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrocyte sodium-lithium countertransport in insulin-dependent diabetics: correlation with membrane lipids, prorenin and micro-albuminuria.
    Lijnen P; Bex M; Bouillon R; Fenyvesi A; Amery A
    J Hypertens Suppl; 1993 Dec; 11(5):S258-9. PubMed ID: 8158373
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum glycoproteins and insulin-dependent juvenile diabetes mellitus].
    Cerutti F; David O; Dianzani I; Guidoni C; Ramenghi U; Vigo A; Sacchetti C
    Minerva Pediatr; 1983 Oct; 35(19):917-20. PubMed ID: 6198584
    [No Abstract]   [Full Text] [Related]  

  • 40. [Indices of the lipid spectrum of the blood serum and erythrocyte membranes in diabetes mellitus in children].
    Turkina TI; Marchenko LF; Sapelkina LV; Kniazeva EM; Andreĭchenko AP
    Probl Endokrinol (Mosk); 1986; 32(5):32-6. PubMed ID: 3538008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.